<https://rdf.molmedb.upol.cz/reference/ref2707> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM473360>,
		<https://identifiers.org/molmedb/MM473363>,
		<https://identifiers.org/molmedb/MM473361>,
		<https://identifiers.org/molmedb/MM473362>,
		<https://identifiers.org/molmedb/MM473359>;
	<http://purl.org/ontology/bibo/pmid> "27914363"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Giacobbo BC, Pissinate K, Rodrigues-Junior V, Villela AD, Grams ES, Abbadi BL, Subtil FT, Sperotto N, Trindade RV, Back DF, Campos MM, Basso LA, Machado P, Santos DS.: New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis. Eur J Med Chem, Volume 126, 2017"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.ejmech.2016.11.048"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://rdf.molmedb.upol.cz/interaction/membrane18> .
<https://rdf.molmedb.upol.cz/interaction/int981361> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2707> .
<https://rdf.molmedb.upol.cz/interaction/int981438> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2707> .
<https://rdf.molmedb.upol.cz/interaction/int981579> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2707> .
<https://rdf.molmedb.upol.cz/interaction/int981506> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2707> .
<https://rdf.molmedb.upol.cz/interaction/int981499> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2707> .